Baxter International, Inc.
One Baxter Parkway
Deerfield
Illinois
60015
United States
Tel: 847-948-2000
Fax: 847-948-3642
Website: http://www.baxter.com/
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
YEAR FOUNDED:
1931
LEADERSHIP:
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
PRODUCTS:
All Products
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
934 articles with Baxter International, Inc.
-
Baxter to Host Annual Meeting of Stockholders in Virtual Format
3/29/2023
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2023 Annual Meeting) in a virtual format on Tuesday, May 2, 2023 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the meeting.
-
Baxter Declares Quarterly Dividend - February 14, 2023
2/14/2023
Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.
-
Baxter Reports Fourth-Quarter and Full-Year 2022 Results
2/9/2023
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.
-
The partners will combine Miromatrix’s single-use bioengineered liver with Baxter’s PrisMax system, which is designed to provide individualized therapies to patients.
-
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
2/1/2023
Miromatrix Medical Inc. (NASDAQ: MIRO) and Baxter International Inc. (NYSE:BAX) today announced a collaborative research agreement to help support additional treatment options for patients with acute liver failure (ALF) in need of organ support therapies.
-
Baxter to Host Fourth-Quarter 2022 Financial Results Conference Call for Investors
1/11/2023
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2022 financial results on Thursday, February 9, 2023 at 7:30 a.m. Central Time.
-
Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders
1/6/2023
Baxter International Inc. announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders.
-
Baxter Named to Dow Jones Sustainability Indices for 23rd Consecutive Year
12/12/2022
Baxter Named to Dow Jones Sustainability Indices for 23rd Consecutive Year.
-
Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting
12/1/2022
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announces the launch of the ExactaMix Pro Automated Compounder, which is expected to be available to customers in the United States in early 2023.
-
Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference
11/16/2022
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
-
Baxter Declares Quarterly Dividend - November 15, 2022
11/15/2022
Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.
-
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
11/7/2022
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida.
-
Baxter Reports Third-Quarter 2022 Results
10/27/2022
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2022.
-
Between top-notch academic institutions, solid venture capital funding, expanding lab space and governmental support, Chicago is emerging as a true hotbed for biotech growth.
-
Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
9/7/2022
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2022 financial results on Thursday, October 27, 2022 at 7:30 a.m. Central Time.
-
Baxter Expands Historically Black Colleges and Universities Partnerships, Funding Commitments to Further the Pipeline of Black Healthcare Professionals
9/7/2022
Baxter International Inc., a global medtech leader, reinforced its commitment to expand the pipeline of Black healthcare professionals through several programs that support Black students pursuing health and science degrees at Historically Black Colleges and Universities.
-
The U.S. Food and Drug Administration had a busy week leading up to the Labor Day holiday. Here’s a look at the agency’s recent activities.
-
Baxter Announces U.S. FDA Clearance of Novum IQ Syringe Infusion Pump with Dose IQ Safety Software
8/31/2022
Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter’s latest developments for infusion therapy.
-
Baxter to Present at the 2022 Wells Fargo Healthcare Conference
8/30/2022
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:25 a.m. Eastern Time.
-
Baxter to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
8/25/2022
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022.